Gemini Therapeutics Inc (GMTX)

NASDAQ
1.42
-0.14(-8.97%)
  • Volume:
    160,596
  • Day's Range:
    1.42 - 1.52
  • 52 wk Range:
    1.16 - 5.48
Earnings results expected tomorrow

GMTX Overview

Prev. Close
1.56
Day's Range
1.42-1.52
Revenue
-
Open
1.52
52 wk Range
1.16-5.48
EPS
-1.58
Volume
160,596
Market Cap
67.43M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
151,747
P/E Ratio
-
Beta
-
1-Year Change
-61.48%
Shares Outstanding
43,227,159
Next Earnings Date
Aug 11, 2022
What is your sentiment on Gemini Therapeutics?
or
Vote to see community's results!

Gemini Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Gemini Therapeutics Inc Company Profile

Gemini Therapeutics Inc Company Profile

Employees
32

Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralBuySell
Technical IndicatorsSellSellBuySellStrong Sell
SummaryNeutralNeutralNeutralNeutralStrong Sell
  • Eliott Wave 5 bearish wave support $4.07 but maybe time to go long now!
    0
    • 6.5
      0
      • good call, congratulations!!!
        0
    • Can anyone tell me if the YATSEN Ticket ysg is a good bet. It entered the IPO Thursday and is $ 17 now.
      0